Home › Non-Small Cell Lung Cancer › Pennsylvania › Harrisburg
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Harrisburg, PA
Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Harrisburg. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg
- UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg · 8 mi ang layo
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Nagre-recruitPhase 2
- UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg
- UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg · 8 mi ang layo
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #104, Hershey · 12 mi ang layo
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Nagre-recruitPhase 3
- UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg
- UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg · 8 mi ang layo
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Nagre-recruitPhase 3
- Penn State Milton S. Hershey Medical Center, Hershey · 12 mi ang layo
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Nagre-recruitPhase 3
- Penn State Milton S. Hershey Medical Center-Penn State Cancer Institute ( Site 0059), Hershey · 12 mi ang layo
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 3
- Research Site, Hershey · 12 mi ang layo
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Nagre-recruitPhase 3
- Research Site, Hershey · 12 mi ang layo
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Nagre-recruitPhase 3
- UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg · 8 mi ang layo
- Penn State Milton S Hershey Medical Center, Hershey · 12 mi ang layo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg
- UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg · 8 mi ang layo
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2/3
- UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg
- UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg · 8 mi ang layo
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
Nagre-recruitPhase 2
- Penn State Cancer Institute, Hershey · 12 mi ang layo
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Harrisburg
- Pagkabigo ng Puso14 pag-aaral
- Kanser sa Suso12 pag-aaral
- Sakit sa Puso at Ugat ng Dugo11 pag-aaral
- Kanser sa Baga9 pag-aaral
- Acute Myeloid Leukemia8 pag-aaral
- Kanser sa Prostate8 pag-aaral
- Colorectal Cancer7 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg7 pag-aaral
- Neuroblastoma6 pag-aaral
- Crohn's Disease6 pag-aaral
- Mataas na Presyon ng Dugo6 pag-aaral
- Kanser (lahat ng uri)5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.